ID Genomics
2815 Eastlake Avenue E # 300
Seattle
Washington
98102
United States
Tel: 206-336-5600
Fax: 206-257-3304
Website: http://idgenomics.com/
Email: info@idgenomics.com
About ID Genomics
ID Genomics is a Seattle-based health technology company that is developing rapid point-of-care diagnostics for infectious disease diagnosis and treatment. Its proprietary CLoNeT™ and BactNet™ DNA fingerprinting-based diagnostics system leverages key discoveries in microbiology and bacterial genomics to improve patient outcomes, decrease costs, and ultimately reduce the spread of infectious diseases. Research has shown that ID Genomics’ technology gives health care providers information about essential characteristics of the infecting bacteria, enabling them to accurately prescribe correct antibiotics for infectious diseases in less than 30 minutes.YEAR FOUNDED:
2012
LEADERSHIP:
Founder: Evgeni Sokurenko
CEO: Kaveri Parker
PRODUCTS:
All Products
FOLLOW ID GENOMICS:
Tweets by ID Genomics
3 articles about ID Genomics
-
Seattle Co Develops Rapid Fingerprinting For COVID-19 Variants
8/24/2021
ID Genomics, a Seattle-based company, has invented a dipstick-based, rapid test for simultaneous identification of a large number of genetic variants of SARS-CoV-2 and has just received a National Institutes of Health grant to expedite bringing this test to market.
-
New Pandemic Superbug Identified by Seattle Company ID Genomics
3/29/2018
Superbug Surpasses Rise of Other E. coli Strains
-
ID Genomics Awarded Prestigious Longitude Prize Discovery Award
8/2/2017